18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
NCT04487847 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2025-01-16
Summary
To study the added value of 18F-PSMA-1007 PET to mpMRI in the detection of local prostate cancer lesions.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
18F-PSMA-1007 PET/CT
18F-PSMA-1007 PET/CT
Sponsors & Collaborators
-
ABX advanced biochemical compounds GmbH
collaborator INDUSTRY -
Radboud University Medical Center
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-01
- Primary Completion
- 2023-02-28
- Completion
- 2023-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
NCT05422105 ·Status: UNKNOWN
-
F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate Cancer
NCT04239742 ·Status: UNKNOWN ·Phase: NA
-
18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer
NCT05815316 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
NCT06723665 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
NCT04742361 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.
NCT03497377 ·Status: COMPLETED ·Phase: PHASE1
-
Prostate Cancer 18F-PSMA-1007 PET/CT Access Trial
NCT06489496 ·Status: NOT_YET_RECRUITING
-
F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence
NCT04102553 ·Status: COMPLETED ·Phase: PHASE3
-
18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study
NCT05707182 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861 ·Status: COMPLETED ·Phase: NA
-
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
NCT03173924 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer
NCT04910425 ·Status: WITHDRAWN ·Phase: PHASE2
-
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
NCT03181867 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study
NCT04176497 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation
NCT06565247 ·Status: RECRUITING ·Phase: PHASE3
-
Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer
NCT03122470 ·Status: WITHDRAWN ·Phase: NA
-
Diagnostic Accuracy and Performance of 18F-PSMA-1007
NCT04986280 ·Status: COMPLETED
-
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147 ·Status: COMPLETED ·Phase: NA
-
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
NCT02420977 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer
NCT00520546 ·Status: COMPLETED ·Phase: PHASE3
-
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
NCT07011342 ·Status: RECRUITING ·Phase: NA
-
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
NCT04298112 ·Status: COMPLETED
-
F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
NCT00963755 ·Status: COMPLETED
-
An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer
NCT04978675 ·Status: COMPLETED ·Phase: PHASE1
-
Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients
NCT04261777 ·Status: TERMINATED ·Phase: PHASE3